Globus Medical plans to buy spinal cord stimulation company Nevro for about $250 million, the companies announced on Thursday. Globus will pay $5.85 per share in an all-cash purchase, a 27% ...

22, 2015 /PRNewswire/ -- Nevro Corp. (NYSE ... for the Senza spinal cord stimulation (SCS) system. According to the approvable letter, approval of the PMA is subject to satisfaction of ...

Nevro Corp is a medical device company. Its key product is the HFX spinal cord stimulation (SCS ... and a mobile charger. The company generates the majority of its revenue in the United States.

Globus Medical’s world is about to get a little bigger, as the orthopedic devicemaker moves to acquire Nevro and its neuromodulation platforms for treating chronic pain. The all-cash deal comes ...

The firm believes Globus gains access to a few assets that are more complimentary than neuromodulation, and it also thinks that if the company can use Nevro’s pain stimulation channel to sell ...